Navigation Links
ProtoKinetix Partners with OTC Financial Network to Increase Shareholder Base
Date:10/14/2008

VANCOUVER, Canada, Oct. 14 /PRNewswire-FirstCall/ -- ProtoKinetix (OTC Bulletin Board: PKTX), a biotech company focused on the research, development and commercialization of patented anti-aging glycopeptides (AAGPs(TM)), announced today that it has partnered with OTC Financial Network (OTCFN), a division of National Financial Communications Corp. (NFC), to direct a comprehensive shareholder awareness campaign.

"ProtoKinetix' AAGP(TM) platform technology is ideal for a number of applications in the skin care/cosmetics, cellular therapy, blood preservation and pharmaceutical industries," said Geoffrey Eiten, president of NFC. "Last month, ProtoKinetix entered into its first licensing agreement to provide AAGP(TM) as the primary active ingredient in an anti-inflammatory cream for the sports injury market. This contract is one of several in the pipeline that position ProtoKinetix on a path to commercial success. We look forward to introducing the Company and its world-class management team to the financial community."

"We've selected to partner with OTCFN to increase our market awareness and widen our shareholder base," said Ross L. Senior, President and CEO of ProtoKinetix Inc. "We are excited to be working with a financial communications firm that has a well respected track record. We believe we can effectively enhance shareholder value by partnering with companies that offer the technical, marketing and distribution expertise to bring AAGP(TM) applications to market."

About OTC Financial Network

Since 1992, OTC Financial Network (OTCFN) has carved its niche as the nation's leading small/micro-cap investor relations and financial communications firm. OTCFN is a division of National Financial Communications Corp. (http://www.nationalfc.com) based in Needham, MA. For information, visit http://www.otcfn.com.

OTC Financial Networ
'/>"/>

SOURCE ProtoKinetix
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65
2. Vista Partners Updates Coverage; Maintains $3.20 Target Price
3. Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership
4. Creators of Britains Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008
5. Mirixa Corporation and the APhA Foundation Form Partnership
6. New Partnership Integrates Vibration Therapy Into Stem Cell Procedures
7. Samaritan Partners Forgetful Rat Model to Taconic to Commercialize
8. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
9. Riverside Partners Sells MicroCal to GE Healthcare
10. onTargetjobs and ClearedConnections Announce Online Recruitment Partnership
11. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... -- Thingee Corporation, a software development company for the Life ... Adoption: Making Reps, Lives Easier" during the 2015 Synergistix ...  in Deerfield Beach, Florida , taking ... to learn how technology can help them do their ... audience for the Thingee presentation. ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Genedata, ... drug discovery and life science research, today announced ... (TM) enterprise platform for use at Pfizer biopharma ... Europe. Genedata is supporting Pfizer’s global deployment and ... (GBT), Centers for Therapeutic Innovation (CTI), and Pharmaceutical ...
(Date:3/3/2015)... FRANCISCO , March 3, 2015  Johnson & ... @ South San Francisco (JLABS @SSF), ... Boulevard, South San Francisco, Calif. ... accommodate up to 50 startups from across the healthcare ... health.  The first resident startups have ...
(Date:3/3/2015)... Nev. , March 3, 2015  PDL BioPharma, ... ) today announced that the third of three shareholder ... dismissed without prejudice. On February 2, 2015, ... last September on behalf of a putative class of ... Inc., et al., No. 2:14-CV-01526-APG-NJK (D. Nev.), was voluntarily ...
Breaking Biology Technology:Thingee to present at 11th Annual Synergistix Users Conference 2Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 2Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 4Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 5PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit 2
... Stallergenes,S.A. officially inaugurates its new pharmaceutical production ... comply with the most stringent EMEA (European Medicines,Agency) ... this unit will,produce desensitisation treatments for all markets, ... worth more than 20 million euros will incorporate ...
... Sept. 10 Signalife, Inc. (Amex:,SGN) announced that the company,s ... stock to be effected in the form of a,reverse stock ... on September,19, 2008, which will be the record date and ... time of such reverse stock split, all,outstanding shares of Signalife ...
... - Abstracts 185 and 1112, Sanofi-aventis, ... from,two randomized clinical studies presented at the European ... Meeting demonstrating that the,"basal plus" insulin strategy with ... insulin) and APIDRA(R) once daily,(prandial insulin) (insulin glulisine ...
Cached Biology Technology:Stallergenes Inaugurates the Biggest Pharmaceutical Allergen Production Unit in the World 2Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment 2Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment 3Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment 4Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment 5Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment 6Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes 2Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes 3Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes 4
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
(Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
(Date:2/5/2015)... OXFORD, Conn. , Jan. 26, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... a new corporate website ( http://www.nxt-id.com/ ) as part ... Wocket™ smart wallet. The Company launched its new consumer ... Gino Pereira , CEO of NXT-ID said, "Our ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marken Launches New Patient-Centric Campaign 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... in cells that may help to kill tumors with heat. ... by a combination of heat and an anti-cancer drug that ... ability of heat to switch off essential survival mechanisms in ... underlying principles are still unclear. In a recent publication ...
... with large, lace-like wings that live in a wide variety ... but the larvae are ferocious predators of other insects, frequently ... after killing them using their enormous, sucking tube-like jaws. ... in the genus Semachrysa is described from the ...
... that the extremely hot, dry and windy conditions on Black ... rolls, -similar to streamers of wind flowing through the air ... the first of its kind to produce such detailed, high-resolution ... for future fire management and warning systems. The work ...
Cached Biology News:Unusual weather events identified during the Black Saturday bushfires 2
Antibodies were affinity purified using epitopes specific to Alpha4 immobilized on solid support....
Prepared in distilled water....
in vitro Translation, Accessory Products...
... Origami host strains are K-12 derivatives ... reductase (trxB) and glutathione reductase (gor) genes, ... the cytoplasm. Studies have shown that expression ... than in another host even though overall ...
Biology Products: